FindTrial
Sign In

Cardiac Contractility Modulation (CCM)

DEVICE3 trials

Sponsors

Ospedale C & G Mazzoni, InCor Heart Institute, Impulse Dynamics

Conditions

Amyloidosis CardiacChagas CardiomyopathyHeart FailureHeart Failure and Reduced Ejection FractionNYHA Class III Heart FailureRight Bundle Branch Block and Left Anterior Fascicular BlockRight Bundle Branch Block and Left Posterior Fascicular BlockSystolic Dysfunction

Unknown Phase

Cardiac Contractility Modulation Therapy in Amyloid Cardiomyopathy Patients With Heart Failure
NCT05167799
Ospedale C & G MazzoniAmyloidosis Cardiac, Heart Failure
Start: 2021-05-13End: 2024-06-01Target: 25Updated: 2021-12-22
Cardiac Contractility Modulation in Chagas Heart Disease
RecruitingNCT05519046
InCor Heart InstituteChagas Cardiomyopathy, Heart Failure, Right Bundle Branch Block and Left Anterior Fascicular Block +2
Start: 2022-05-25End: 2026-12-31Target: 60Updated: 2025-04-04
Propensity-Matched Study of Cardiac Contractility Modulation Therapy in Heart Failure
RecruitingNCT07209098
Impulse DynamicsHeart Failure and Reduced Ejection Fraction, NYHA Class III Heart Failure
Start: 2025-11-18End: 2031-04-01Target: 4200Updated: 2026-03-24

Related Papers

Efficacy of Contractility Modulation Therapy in Patients with Transthyretin Amyloid Cardiomyopathy, Mildly Reduced to Reduced EF and NYHA III and IV: A Multicentric, Prospective Pilot Study for AMY-CCM Registry
Journal of Cardiovascular Development and Disease2025-09-251 citations